Rosenberg, J. E., Halabi, S., Sanford, B. L., Himelstein, A. L., Atkins, J. N., Hohl, R. J., . . . Small, E. J. (2008). Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. Ann Oncol.

Rosenberg, J. E., S. Halabi, B. L. Sanford, A. L. Himelstein, J. N. Atkins, R. J. Hohl, F. Millard, D. F. Bajorin, e E. J. Small. "Phase II Study of Bortezomib in Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma: CALGB 90207." Ann Oncol 2008.

Rosenberg, J. E., et al. "Phase II Study of Bortezomib in Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma: CALGB 90207." Ann Oncol 2008.